We investigate the anatomy and function of brain circuits from molecules to functional MRI.
We conceive, manufacture, validate implantable and wearable neural interfaces.
We model and simulate how the brain works leveraging advances in artificial intelligence ad machine learning and use this new knowledge to derive innovative computing schemes and algorithms.
The cross-fertilization of these three research domains in a continuous translational effort will allow us to dramatically accelerate the pace of delivery of new therapies to patients, in collaboration with our clinical partners (CHUV, HUG, CRR in Switzerland and multiple clinical institutions worldwide).
With its main hub at the vibrant Campus Biotech, where we work and share experimental resources with our colleagues from the University of Geneva and Geneva University Hospital. We also operate clinical interfaces in Lausanne (NeuroRestore) and Sion (with the Clinique Romande de Réhabilitation). These multiple facets of our activities reflect our burgeoning and collaborative way of working, crossing the boundaries of campuses and disciplines to better build the future of neurotherapies.
Our locationsThe Neuro X section offers a new master program, that will train students in fundamental neurosciences, neurotechnologies and artificial intelligence. This broad curriculum will allow future EPFL engineers to contribute to fundamental or translational research, clinical applications, product development… in academic research, clinical settings as well as in the medtech industry.
In many instances, our collaborators have developed an entrepreneurial spirit, which has led in the past to the creation of many successful companies. Bringing together neuroscientists, engineers, computer scientists and physicians under one roof is poised to even accelerate the pace of value creation.